Fortress Biotech is trading below its cash balance, offering deep value relative to its assets and financial improvements.

Investors have plenty of crosscurrents of news and economic stats to ponder when looking for new stocks these days, but the breakout in biotech stocks is one definite that has become clear, as ...

The recent rally in biotechnology stocks is being driven by improving fundamentals and a resurgence in merger activity rather than speculative excess, according to Jonathan Faison, founder of ROTY ...

As Q2 2026 earnings season approaches, healthcare stocks are drawing investor attention as markets assess demand across care delivery, diagnostics, life sciences, pharmaceuticals, medical devices, and ...